Fommei E, Ghione S, Palla L, Rosa C, Mosca F, Ferrari M, Palombo C, Donato L
J Hypertens Suppl. 1985 Nov;3(2):S137-8.
Recent studies have reported that captopril can acutely induce a marked decrease of glomerular filtration rate in kidneys affected by renal artery stenosis, an effect detectable by scintigraphic techniques. Experience which confirms and extends this observation, obtained in five patients with renovascular hypertension, is reported here. For comparison, eight essential hypertensives and six patients with non-vascular unilateral renal diseases were studied. In each patient the ratio of glomerular filtration rate between the two kidneys was estimated during two consecutive scintigraphic studies with the glomerular tracer 99mTc-DTPA: in all renovascular patients captopril induced a marked decrease of glomerular filtration rate on the affected side, whereas negligible changes were observed in all other subjects. These results confirm that captopril may almost completely suppress glomerular filtration in kidneys affected by unilateral renal artery stenosis, an effect which may not be apparent clinically because of compensation by the other kidney, but which is scintigraphically detectable. Renal scintigraphy after captopril is easy to perform and non-invasive. It therefore seems to be a promising tool for the screening of renovascular hypertension.
近期研究报告称,卡托普利可使肾动脉狭窄所累及的肾脏的肾小球滤过率急剧显著下降,这种效应可通过闪烁扫描技术检测到。本文报告了在5例肾血管性高血压患者中所获得的证实并扩展这一观察结果的经验。作为对照,对8例原发性高血压患者和6例非血管性单侧肾脏疾病患者进行了研究。在每位患者中,通过连续两次使用肾小球示踪剂99mTc-DTPA的闪烁扫描研究来估算两侧肾脏之间的肾小球滤过率比值:在所有肾血管性疾病患者中,卡托普利使患侧的肾小球滤过率显著下降,而在所有其他受试者中观察到的变化可忽略不计。这些结果证实,卡托普利几乎可完全抑制单侧肾动脉狭窄所累及肾脏的肾小球滤过,这种效应由于对侧肾脏的代偿作用在临床上可能不明显,但可通过闪烁扫描检测到。卡托普利后的肾脏闪烁扫描操作简便且无创。因此,它似乎是一种很有前景的肾血管性高血压筛查工具。